Literature DB >> 7065755

Survival with carcinoma arising in mucosal ulcerative colitis.

I C Lavery, R A Chiulli, D G Jagelman, V W Fazio, F L Weakley.   

Abstract

Adenocarcinoma of the colon is a well-recognized complication of total chronic ulcerative colitis. The incidence increases with time, and the carcinoma arising in chronic ulcerative colitis has developed a bad clinical reputation in terms of aggressive behavior. The survival statistics of patients with cancer arising in chronic ulcerative colitis are compared with statistics for a group of noncolitic patients with equivalent clinicopathologic staging treated at the same institution. When grouped by extended Duke's classification and compared with carcinoma arising without ulcerative colitis, there was no statistical difference in survival rates. The overall results are worse because of a higher percentage of patients with incurable disease at the time of operation. With improved surveillance and methods of detecting premalignant changes, the necessity for prophylactic proctocolectomy should decline.

Entities:  

Mesh:

Year:  1982        PMID: 7065755      PMCID: PMC1352536          DOI: 10.1097/00000658-198204000-00021

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  Cancer risk and life expectancy of children with ulcerative colitis.

Authors:  G J Devroede; W F Taylor; W G Sauer; R J Jackman; G B Stickler
Journal:  N Engl J Med       Date:  1971-07-01       Impact factor: 91.245

2.  Ileorectal anastomosis: review 1952-1968.

Authors:  S O Aylett
Journal:  Proc R Soc Med       Date:  1971-09

3.  Factors in prognosis of colon and rectal cancer.

Authors:  O H Beahrs; P M Sanfelippo
Journal:  Cancer       Date:  1971-07       Impact factor: 6.860

4.  Cancer of the colon. The five- and ten-year survival rates following resection utilizing the isolation technique.

Authors:  R B Turnbull
Journal:  Ann R Coll Surg Engl       Date:  1970-05       Impact factor: 1.891

5.  Carcinoma associated with mucosal ulcerative colitis, and with transmural colitis and enteritis (Crohn's disease).

Authors:  R G Farmer; W A Hawk; R B Turnbull
Journal:  Cancer       Date:  1971-08       Impact factor: 6.860

6.  Local complications of ulcerative colitis: stricture, pseudopolyposis, and carcinoma of colon and rectum.

Authors:  F T De Dombal; J M Watts; G Watkinson; J C Goligher
Journal:  Br Med J       Date:  1966-06-11

7.  Cancer of the colon: the influence of the no-touch isolation technic on survival rates.

Authors:  R B Turnbull; K Kyle; F R Watson; J Spratt
Journal:  Ann Surg       Date:  1967-09       Impact factor: 12.969

8.  Rectal biopsy as an aid to cancer control in ulcerative colitis.

Authors:  B C Morson; L S Pang
Journal:  Gut       Date:  1967-10       Impact factor: 23.059

9.  Risk of malignant change in ulcerative colitis.

Authors:  J M Hinton
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

10.  Cancer in ulcerative colitis.

Authors:  B C Morson
Journal:  Gut       Date:  1966-10       Impact factor: 23.059

View more
  20 in total

Review 1.  Screening for colorectal cancer in ulcerative colitis: dubious benefits and high costs.

Authors:  S Gyde
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

2.  Deacetylation by SIRT1 Reprograms Inflammation and Cancer.

Authors:  Tie Fu Liu; Charles E McCall
Journal:  Genes Cancer       Date:  2013-03

3.  Clinicopathological features of ulcerative colitis-associated colorectal cancer pointing to efficiency of surveillance colonoscopy in a large retrospective Japanese cohort.

Authors:  Hiroki Matsuoka; Hiroki Ikeuchi; Motoi Uchino; Toshihiro Bando; Yoshio Takesue; Takayuki Nishigami; Naohiro Tomita
Journal:  Int J Colorectal Dis       Date:  2012-10-19       Impact factor: 2.571

4.  Clinical outcome of IBD-associated versus sporadic colorectal cancer: a matched-pair analysis.

Authors:  Bernhard W Renz; Wolfgang E Thasler; Gerhard Preissler; Tobias Heide; Philippe N Khalil; Michael Mikhailov; Karl-Walter Jauch; Martin E Kreis; Markus Rentsch; Axel Kleespies
Journal:  J Gastrointest Surg       Date:  2013-03-09       Impact factor: 3.452

Review 5.  A meta-analysis of the clinicopathological characteristics and survival outcomes of inflammatory bowel disease associated colorectal cancer.

Authors:  Ian S Reynolds; Aobhlinn O'Toole; Joseph Deasy; Deborah A McNamara; John P Burke
Journal:  Int J Colorectal Dis       Date:  2017-01-11       Impact factor: 2.571

Review 6.  Cancer in inflammatory bowel disease.

Authors:  A J Greenstein; A Sugita; Y Yamazaki
Journal:  Jpn J Surg       Date:  1989-11

7.  Compliance, cost, and common sense limit cancer control in colitis.

Authors:  J E Lennard-Jones
Journal:  Gut       Date:  1986-12       Impact factor: 23.059

8.  Review of clinical aspects of cancer of the colon in patients with ulcerative colitis.

Authors:  R P MacDermott
Journal:  Dig Dis Sci       Date:  1985-12       Impact factor: 3.199

9.  Surveillance of patients with chronic ulcerative colitis. WHO Collaborating Centre for the Prevention of Colorectal Cancer.

Authors:  B Levin; J Lennard-Jones; R H Riddell; D Sachar; S J Winawer
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

10.  Survival of patients with colorectal cancer complicating ulcerative colitis.

Authors:  S N Gyde; P Prior; H Thompson; J A Waterhouse; R N Allan
Journal:  Gut       Date:  1984-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.